Ignite Creation Date:
2024-05-06 @ 3:25 AM
Last Modification Date:
2024-10-26 @ 11:33 AM
Study NCT ID:
NCT02289222
Status:
TERMINATED
Last Update Posted:
2019-11-05
First Post:
2014-10-17
Brief Title:
1454GCC Anti-PD-1 MK-3475 and IMiD Pomalidomide Combination Immunotherapy in RelapsedRefractory Multiple Myeloma
Sponsor:
Ashraf Badros
Organization:
University of Maryland Baltimore
Organization Data
Organization:
University of Maryland Baltimore
Class:
OTHER
Study ID:
HP-00061522 GCC1454
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ashraf Badros
Lead Sponsor Class:
OTHER
Responsible Party:
Ashraf Badros
Responsible Party Title:
Sponsor-Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Maryland Baltimore
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |